참고문헌
- Asanuma H, Torigoe T, Kamiguchi K, et al (2005). Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res, 65, 11018-25. https://doi.org/10.1158/0008-5472.CAN-05-0491
- Ballou LM, Lin RZ (2008). Rapamycin and mTOR kinase inhibitors. J Chem Biol, 1, 27-36. https://doi.org/10.1007/s12154-008-0003-5
- Burz C, Berindan-Neagoe I, Balacescu O, Irimie A (2009). Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta oncologica, 48, 811-21. https://doi.org/10.1080/02841860902974175
- GLOBOCAN 2008 (IARC), S. o. C. I. (2008). Section of Cancer Information (29/8/2013)
- Gullino P, Pettigrew HM, Grantham F (1975). N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst, 54, 401-14.
- Hahm H, Davidson N (1998). Apoptosis in the mammary gland and breast cancer. Endocrine-related cancer, 5, 199-211. https://doi.org/10.1677/erc.0.0050199
- Hassan Z K, Elamin M H, Omer S A, et al (2013). Oleuropein induces apoptosis via the p53 pathway in breast cancer cells. Asian Pac J Cancer Prev, 14, 6739-42. https://doi.org/10.7314/APJCP.2013.14.11.6739
- Hengartner M O (2000). The biochemistry of apoptosis. Nature, 407, 770-76. https://doi.org/10.1038/35037710
- Huang K, Huang Y, Diao Y (2012). Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int Immunopharmacol, 12, 334-41. https://doi.org/10.1016/j.intimp.2011.12.004
- Huynh H (2010). Molecularly targeted therapy in hepatocellular carcinoma. Biochemical Pharmacol, 80, 550-60. https://doi.org/10.1016/j.bcp.2010.03.034
- Jaafar H, Abdullah S, Murtey M D, Idris F M (2012). Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors. Asian Pac J Cancer Prev, 13, 3857-62. https://doi.org/10.7314/APJCP.2012.13.8.3857
- Jaafar H, Idris F M, Nafi S N M (2009). The association between phenotype and size of breast tumors induced by 1-methyl-1-nitrosourea (MNU) injection in rats. Med Sci Monit, 15.
- Jha K, Shukla M, Pandey M (2012). Survivin expression and targeting in breast cancer. Surgical Oncology, 21, 125-31. https://doi.org/10.1016/j.suronc.2011.01.001
- Jurgensmeier J M, Xie Z, Deveraux Q, et al (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA, 95, 4997-5002. https://doi.org/10.1073/pnas.95.9.4997
- Lu J, Tan M, Huang WC, et al (2009). Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clin Cancer Res, 15, 1326-34. https://doi.org/10.1158/1078-0432.CCR-08-0954
- Maione T E, Gray G S, Hunt A J, Sharpe R J (1991). Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res, 51, 2077-83.
- Namba R, Young L J, Abbey C K, et al (2006). Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clinical Cancer Res, 12, 2613-21. https://doi.org/10.1158/1078-0432.CCR-05-2170
- Noh WC, Mondesire W H, Peng J, et al (2004). Determinants of rapamycin sensitivity in breast cancer cells. Clinical Cancer Res, 10, 1013-23. https://doi.org/10.1158/1078-0432.CCR-03-0043
- Purcell J W, Davis J, Reddy M, et al (2010). Activity of the kinesin spindle protein inhibitor ispinesib (SB-715992) in models of breast cancer. Clinical Cancer Res, 16, 566-76. https://doi.org/10.1158/1078-0432.CCR-09-1498
- Reed J (1996). Balancing cell life and death: bax, apoptosis, and breast cancer. J Clin Invest, 97, 2403. https://doi.org/10.1172/JCI118684
- Russo J, Russo I H (1995). The etiopathogenesis of breast cancer prevention. Cancer letters, 90, 81-9. https://doi.org/10.1016/0304-3835(94)03681-8
- Russo J, Russo I H (2000). Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia, 5, 187-200. https://doi.org/10.1023/A:1026443305758
- Samkari A, Cooper Z A, Holloway M P, Liu J, Altura R A (2012). Rapamycin induces the anti-apoptotic protein survivin in neuroblastoma. Int J Biochem Mol Biol, 3, 28.
- Shirouzu Y, Ryschich E, Salnikova O, et al (2010). Rapamycin inhibits proliferation and migration of hepatoma cells. J Surg Res, 159, 705-13. https://doi.org/10.1016/j.jss.2008.07.035
- Shor B, Gibbons J J, Abraham R T, Yu K (2009). Targeting mTOR globally in cancer: thinking beyond rapamycin. Cell Cycle, 8, 3831-7. https://doi.org/10.4161/cc.8.23.10070
- Signore M, Ricci-Vitiani L, De Maria R (2013). Targeting apoptosis pathways in cancer stem cells. Cancer letters, 332, 374-82. https://doi.org/10.1016/j.canlet.2011.01.013
- Tan M L, Ooi J P, Ismail N, Moad A I H, Muhammad T S T (2009). Programmed cell death pathways and current antitumor targets. Pharmaceutical Res, 26, 1547-60. https://doi.org/10.1007/s11095-009-9895-1
- Tanaka K, Iwamoto S, Gon G, et al (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clinical Cancer Res, 6, 127-34.
- Thompson H J, McGinley J N, Rothhammer K, Singh M (1995). Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis, 16, 2407-12. https://doi.org/10.1093/carcin/16.10.2407
- Verdecia M A, Huang Hk, Dutil E, et al (2000). Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nature Structural Molec Biol, 7, 602-8. https://doi.org/10.1038/76838
- Wan L Z, Hu N, Liu XJ, et al (2014). Fangchinoline Inhibits cell proliferation via Akt/GSK-3beta/cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells. Asian Pac J Cancer Prev, 15, 769-73. https://doi.org/10.7314/APJCP.2014.15.2.769
- Yip C H, Taib N A, Mohamed I (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev, 7, 369-74.
- Zhou J, Luo YH, Wang JR, Lu BB, Tian Y (2013). Gambogenic acid induction of apoptosis in a breast cancer cell line. Asian Pac J Cancer Prev, 14, 7601-05. https://doi.org/10.7314/APJCP.2013.14.12.7601
- Zhu N, Gu L, Findley H W, Li F, Zhou M (2004). An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Oncogene, 23, 7545-51. https://doi.org/10.1038/sj.onc.1208038
피인용 문헌
- Correlation of Tumour Response with Starting Tumour Size and Dose of Tamoxifen in an N-Methyl-N-Nitrosourea (NMU)-Induced Rat Mammary Cancer Model vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6721
- Lack of Relation of Survivin Gene Expression with Survival and Surgical Prognostic Factors in Endometrial Carcinoma Patients vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6905
- Upregulation of HIF-1α by Hypoxia Protect Neuroblastoma Cells from Apoptosis by Promoting Survivin Expression vol.15, pp.19, 2014, https://doi.org/10.7314/APJCP.2014.15.19.8251
- Effects of Rapamycin on Cell Apoptosis in MCF-7 Human Breast Cancer Cells vol.15, pp.24, 2014, https://doi.org/10.7314/APJCP.2014.15.24.10659